Actual Medicinal Product (AMP) Desloratadine 5mg tablets (Rivopharm (UK) Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends storing in original container. No stability data in MCAs available.
- Provenance
-
This recommendation is based on the products Neoclarityn 5mg film-coated tablets (Organon Pharma (UK) Limited) and desloratadine 5mg film-coated tablets (Mylan).
- Generic
- Desloratadine
- Formulation
- Desloratadine 5mg tablets
-
Desloratadine
-
Desloratadine 5mg tablets
-
Desloratadine 5mg tablets (Rivopharm (UK) Ltd)
-
-